Ovarian Cancer

Nyhet

Disease, Diagnosis, and Treatment

Häftad, Engelska, 2025

Av Bhupendra G. Prajapati, Mehul Chorawala, Seema Jadav, India) Prajapati, Bhupendra G., PhD (Parul Institute of Pharmacy, Faculty of Pharmacy, Parul University, Waghodia, Vadodara, Gujarat, India) Chorawala, Mehul, PhD. (Assistant Professor, L. M. College of Pharmacy, Ahmedabad, Gujarat, PhD (Sanofi Pharmaceutical) Jadav, Seema, Bhupendra G Prajapati

2 259 kr

Beställningsvara. Skickas inom 7-10 vardagar

Fri frakt för medlemmar vid köp för minst 249 kr.

By providing a comprehensive overview of current research findings, emerging therapies, and clinical practices, Ovarian Cancer: Disease, Diagnosis and Treatment is an invaluable resource. It will not only enhance the understanding of ovarian cancer's complex biology among professionals but also guide them in applying this knowledge to improve patient outcomes The book delivers the key knowledge and information needs faced by the audience center around understanding the latest advances in the underlying pathogenesis and treatment of ovarian cancer. This encompasses a broad spectrum of requirements, from grasping the molecular and genetic factors driving ovarian cancer development to staying updated on the latest therapeutic strategies, including targeted therapies and immunotherapies. In 19 chapters Ovarian Cancer: Disease, Diagnosis and Treatment gives a timely and comprehensive coverage of advances in ovarian cancer therapy, particularly highlighting the development and utilization of Nanotheranostics technologies. This focus not only addresses a crucial and cutting-edge area of cancer treatment but also positions the book as a forward- thinking resource that delves into the potential of Nanotheranostics to revolutionize cancer diagnostics and therapy.

Ovarian Cancer: Disease, Diagnosis and Treatment targets a specialized audience within the medical and scientific community, focusing on obstetricians and gynecologists, oncologists, cancer researchers, and importantly, patients with ovarian cancer. This audience selection underscores the project's dual aim of advancing scientific knowledge and directly benefiting patient care in the realm of ovarian cancer, bridging the gap between research, clinical application, and patient advocacy.

Provides a comprehensive understanding of ovarian cancer
Gives insight in the diagnostics and treatment strategies of ovarian cancer
Describes the drugs used and novel formulation for targeting the treatment of ovarian cancer

Produktinformation

Utgivningsdatum2025-09-29
Mått191 x 235 x 27 mm
Vikt450 g
FormatHäftad
SpråkEngelska
Antal sidor496
FörlagElsevier Science
ISBN9780443335365

Tillhör följande kategorier

Dr. Bhupendra Gopalbhai Prajapati is a Professor (Research Cadre) at Parul Institute of Pharmacy, Parul University, Gujarat, India. He is also acting as Adjunct Professor at Department of Industrial Pharmacy, Faculty of Pharmacy, Silpakorn University, Thailand. With over 22 years of experience in academia, research, and industry, he specializes in lipid-based formulations, nano/microparticulate drug delivery, and bioavailability enhancement. A recipient of several prestigious awards including the AICTE Young Teacher Award and Ganpat University's Staff Excellence honors, Dr. Prajapati has published over 350 research/review papers, and has contributed to more than 170 book chapters. He actively mentors Ph.D. and PG scholars and serves as editor or section editor for several international publications in pharmaceutical sciences. Dr. Mehul R. Chorawala works as an assistant professor at L. M. College of Pharmacy, Ahmedabad, Gujarat, India. He is an alumnus of the University of Iowa, IA, USA (Postdoctoral Fellow). He has decades of academic and industry experience mainly focusing on research. He published more dozens of international and national peer reviewed publications along with several books. He is an active member of American Heart Association (AHA) and Indian Pharmacological Society. His current research focus is on immune-inflammation, oxidative-nitrosative stress, medical oncology, metabolic disorders such as diabetes mellitus and its complications.Ms.Seema Jadav works as a Clinical Pharmacist in the UK. She received her Bachelor’s degree in Pharmacy from S.P. University in India and Masters in Public Health degree from Curtin University, Australia. She then moved to the U.K where she registered as a pharmacist. She currently works in a General Practitioner surgery alongside doctors, nurses and other health care professionals. She previously worked as a mental health pharmacist in hospitals for eight years for patients with critical disease. Whilst in this role she also acquired a Post Graduate Certificate in Psychiatric Therapeutics. She is now going to work towards securing a prescribing qualification to become a pharmacist prescriber with special interest in mental health, cancer, diabetes and hypertension.

1. Understanding Ovarian Cancer2. Epithelial Ovarian Cancer: The Most Common Subtype3. Germ Cell Tumors: Ovarian Cancer in Young Women4. Stromal Tumors: Exploring Rare Ovarian Cancer Types5. Ovarian Oncosomes6. Potential role of Microbiome in ovarian cancer7. Early Detection Matters: Screening and Diagnostic Tools8. Targeting Mitochondria for Treatment of Ovarian Cancer9. Surgical Interventions: Reshaping the Battle against Ovarian Cancer10. Natural Drugs for Ovarian Cancers11. Novel Synthetic molecules for Ovarian Cancer12. Chemotherapy: A Powerful Weapon in Ovarian Cancer Treatment13. Radiation Therapy: Targeting Ovarian Cancer with Precision14. Nanoparticles in treating Ovarian Cancer15. Liposomes in treating Ovarian Cancer16. Therapeutic Vaccines for Ovarian Cancer17. The Genetic Puzzle: BRCA Mutations and Personalized Medicine18. Life Beyond Treatment: Nurturing Survivorship19. Monitoring for Recurrence: Follow-Up Care and Surveillance